| Health professionals | ||||||||||
Waikato DHB Palliative Care Guidelines6. Dyspnoea
6.1 MorphineMorphine is very useful in the management of dyspnoea.Usually lower doses are required than those for pain e.g. 2.5 - 10mg of elixir 4 hourly or PRN. The dose can be gradually titrated as for pain but comfort rather than resolution of dyspnoea is generally the desired end point. If a trial of elixir has proved helpful a low dose of M-Eslon™ or low dose morphine infusion may be more convenient however, patients may choose to remain on regular elixir. Nebulised morphine has NO demonstrable advantage over morphine elixir. 6.2 BenzodiazepinesClonazepam oral drops 2.5mg/ml (1 drop = 0.1mg) 1-3 drops 4-6 hourly PRN.Lorazepam 0.5 - 1mg PO 4 - 6 hourly. Midazolam 10 – 20mg/24hours via subcut infusion. Available by special authority - see Pharmac website or check with the hospital pharmacist (relevant specialist only). Sedation is sometimes needed and morphine plus a benzodiazepine via subcut infusion is recommended. 6.3 SteroidsRecommended for bronchial obstruction, superior vena cava obstruction (SVCO), radiation pneumonitis and lymphangitis carcinomatosis.Therapeutic trial can sometimes be worthwhile if cause unclear. Either prednisone 20-40mg mane or dexamethasone 8-12mg mane – depending on cause and then aim to reduce gradually to lowest effective dose. 6.4 OxygenThe use of oxygen in a non-cyanotic patient is controversial but there is extensive anecdotal evidence to warrant a trial if other measures have failed.6.5 Non-pharmacological treatmentsVery important consideration.Physiotherapy, occupational therapy, counselling, relaxation and music therapy all have a role in the management of dyspnoea.
|